What archival evidence links private chemical firms and IG Farben to Zyklon B deliveries to camps?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Archival records and postwar trial documents establish that Zyklon B was manufactured and marketed by firms connected to IG Farben—principally through the pesticide company Degesch, in which IG Farben held a substantial ownership stake—and that Degesch-branded Zyklon B was supplied to Nazi concentration and extermination camps [1] [2] [3]. The documentary record is extensive (including Nuremberg trial files and corporate minutes) about ownership, sales and the product’s use as a pesticide, but courts and some corporate histories note limits in the archives for proving which senior IG Farben executives knew of or authorized the product’s deliberate homicidal use [1] [4].
1. Trial archives and documented supply chains: what the Nuremberg record shows
The Subsequent Nuremberg trials and related archival collections contain volumes of primary material tying Zyklon B to Degesch and linking Degesch to IG Farben ownership and board representation: trial exhibits and law reports repeatedly record that Degesch marketed Zyklon B and that IG Farben held a 42.5 percent stake in Degesch from 1930 [2] [1] [5], while published compilations note extensive documentation presented in the IG Farben case and related prosecutions [6] [2].
2. Corporate structure and control: IG Farben’s legal and financial connections
Multiple institutional histories and museum and memorial sources document IG Farben’s financial and managerial ties to the Zyklon B supply chain: Degussa and IG Farben each held major shares in Degesch, IG Farben appointed directors to Degesch’s supervisory boards, and IG Farben subsidiaries and managers were involved in the commercial network that produced and stabilized hydrogen cyanide products later sold under the Zyklon B name [2] [5] [1].
3. Documentary evidence of sales, distribution and camp use
Archival testimony and business records introduced at trials and preserved by memorial archives demonstrate that Zyklon B was marketed as a pesticide and that sales increased steeply during the war, with Degesch-labeled product becoming a standard commodity; courtroom exhibits, corporate minutes and sales documentation shown at trials were used to establish that Zyklon B reached concentration and extermination camps [2] [6] [7]. Secondary sources and contemporary reporting summarize that Degesch-supplied Zyklon B was the cyanide-based agent used in Auschwitz and Majdanek [1] [3].
4. Gaps, contested inferences and judicial caution about culpability
Despite voluminous archives proving production, ownership and distribution links, judicial findings and later corporate histories stress limits in the surviving documents for establishing who in IG Farben knew the full genocidal intent: the IG Farben trial judges concluded that, based on surviving documents and testimony, it could not be proven beyond doubt that certain executives (for example Carl Wurster) knew Zyklon B was being misused to kill people, and corporate histories reiterate this evidentiary boundary [1] [4]. In short, archival evidence tightly connects firms and products but does not uniformly document explicit, contemporaneous direct orders from every senior IG Farben executive to supply Zyklon B for mass murder [1].
5. The archival footprint available to researchers today
Researchers have access to massive primary materials—trial volumes, photographic exhibits, corporate records and memorial archives—documenting the commercial production, ownership stakes, sales records and the use of Zyklon B, and institutions such as the Wollheim memorial and the USHMM host related source material and indexes from the trials and company files [2] [6] [7]. At the same time, institutional statements from successor companies and court rulings cited in corporate histories acknowledge that documentary ambiguities remain about individual knowledge and intent among senior executives [1] [8].
Conclusion
Archival evidence incontrovertibly links Degesch—and through shareholding and board representation, IG Farben—to the manufacture, branding and commercial distribution of Zyklon B and shows that Degesch-supplied Zyklon B reached Nazi extermination camps; this link is documented across Nuremberg trial records, memorial archives and contemporary histories [2] [6] [3]. What remains contested in the archival record—and what courts emphasized—is the degree to which specific top IG Farben executives can be proven, from surviving documents alone, to have known and ordered the product’s homicidal use, a limitation acknowledged in company histories and trial findings [1] [4].